MAIA Biotechnology Inc.(MAIA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

MAIA MAIA Biotechnology Inc.

Post-Mkt 10-16 19:23:35 EDT

1.10

-0.02

-1.79%

盘后1.11

+0.01+0.80%

19:01 EDT

High1.15	Low1.08	Vol363.52K
Open1.13	D1 Closing1.12	Amplitude6.25%
Mkt Cap67.92M	Tradable Cap60.83M	Total Shares61.74M
T/O400.01K	T/O Rate0.66%	Tradable Shares55.30M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"MAIA","market":"US","secType":"STK","nameCN":"MAIA Biotechnology Inc.","latestPrice":1.1,"timestamp":1792180800000,"preClose":1.12,"halted":0,"volume":363521,"hourTrading":{"tag":"盘后","latestPrice":1.1088,"preClose":1.1,"latestTime":"19:01 EDT","volume":356,"amount":392.4019968,"timestamp":1792191698514,"change":0.0088,"changeRate":0.008,"amplitude":0.027273},"delay":0,"changeRate":-0.01785714285714287,"floatShares":55296811,"shares":61741899,"eps":-0.608478,"marketStatus":"Post-Mkt","change":-0.02,"latestTime":"10-16 19:23:35 EDT","open":1.13,"high":1.15,"low":1.08,"amount":400009.9656565,"amplitude":0.0625,"askPrice":1.2,"askSize":200,"bidPrice":1,"bidSize":500,"shortable":3,"etf":0,"ttmEps":-0.608478,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1792195200000},"marketStatusCode":4,"adr":0,"listingDate":1659067200000,"exchange":"AMEX","adjPreClose":1.12,"preHourTrading":{"tag":"盘前","latestPrice":1.14,"preClose":1.12,"latestTime":"09:21 EDT","volume":50,"amount":56.99999999999999,"timestamp":1792156870149,"change":0.02,"changeRate":0.017857,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":1.1088,"preClose":1.1,"latestTime":"19:01 EDT","volume":356,"amount":392.4019968,"timestamp":1792191698514,"change":0.0088,"changeRate":0.008,"amplitude":0.027273},"volumeRatio":1.005114},"requestUrl":"/m/hq/s/MAIA/tweets","defaultTab":"tweets","newsList":[{"id":"2673701836","title":"Maia Biotech Completes Enrollment for THIO-101 Phase 2 NSCLC Trial of Ateganosine Plus Cemiplimab","url":"https://stock-news.laohu8.com/highlight/detail?id=2673701836","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673701836?lang=en_us&edition=fundamental","pubTime":"2026-10-07 20:15","pubTimestamp":1791375317,"startTime":"0","endTime":"0","summary":"Maia Biotech completes enrollment for THIO-101 Phase 2 NSCLC trial of ateganosine plus cemiplimabMaia Biotechnology hit an enrollment milestone across ongoing Phase 2 THIO-101 and pivotal Phase 3 THIO","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261007:nNDL1z1FDW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2T93.GBP","LU2095319765.USD","NDAQ","LU0314104364.USD","BK4585","LU2210150020.SGD","MAIA","IE00B64PRP62.GBP","SG9999014005.SGD","SG9999014013.SGD","IE00B3QW5Z07.USD","IE00BN0W2V16.EUR","IE00BGHQF748.EUR","IE00BQXX3F31.USD","BCDF","IE00BQXX3D17.EUR","SG9999014021.USD","BK4588","SG9999014039.USD","BK4139","LU2210149790.SGD","IE00BKPKM429.USD","IE00BQXX3C00.GBP","IE00BN0W2W23.USD","BK4112"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673901833","title":"Maia Biotechnology Achieves Patient Enrollment Milestones in Ongoing Phase 2 and Pivotal Phase 3 Clinical Trials in Non-Small Cell Lung Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2673901833","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673901833?lang=en_us&edition=fundamental","pubTime":"2026-10-07 20:15","pubTimestamp":1791375300,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261007:nTUABTD9KB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","MAIA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673059709","title":"MAIA Biotechnology Releases New Investor Presentation and Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2673059709","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673059709?lang=en_us&edition=fundamental","pubTime":"2026-10-06 20:51","pubTimestamp":1791291075,"startTime":"0","endTime":"0","summary":"MAIA Biotechnology, Inc. ( ($MAIA) ) just unveiled an announcement. On October 6, 2026, MAIA Biotechnology, Inc. posted a new investor presentation...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/maia-biotechnology-releases-new-investor-presentation-and-update?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/maia-biotechnology-releases-new-investor-presentation-and-update?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","MAIA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672752098","title":"Diamond Equity releases update note on MAIA Biotechnology","url":"https://stock-news.laohu8.com/highlight/detail?id=2672752098","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672752098?lang=en_us&edition=fundamental","pubTime":"2026-10-01 20:37","pubTimestamp":1790858225,"startTime":"0","endTime":"0","summary":"Diamond Equity Research, an equity research firm with a focus on small capitalization public companies has released an update note on MAIA Biotechn...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/diamond-equity-releases-update-note-on-maia-biotechnology-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/diamond-equity-releases-update-note-on-maia-biotechnology-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MAIA","BK4215","BK4585","BK4139","EQR","REZ","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670422979","title":"MAIA Biotechnology files to sell 751,879 shares of common stock for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2670422979","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670422979?lang=en_us&edition=fundamental","pubTime":"2026-09-26 05:05","pubTimestamp":1790370309,"startTime":"0","endTime":"0","summary":"This filing relates to the offer and sale from time to time by the selling stockholders of up to 751,879 shares of common stock. The company is not...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/maia-biotechnology-files-to-sell-751879-shares-of-common-stock-for-holders-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/maia-biotechnology-files-to-sell-751879-shares-of-common-stock-for-holders-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","MAIA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670242256","title":"Maia Biotechnology - Selling Stockholder Offering 751,879 Shares of Maia Biotechnology Common Stock - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2670242256","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670242256?lang=en_us&edition=fundamental","pubTime":"2026-09-26 05:04","pubTimestamp":1790370267,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260925:nFWN45H13G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MAIA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669898284","title":"Maia Biotech Wins Spanish, Portuguese Regulatory Clearance to Screen Patients in THIO-104 Lung Cancer Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2669898284","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669898284?lang=en_us&edition=fundamental","pubTime":"2026-09-23 21:17","pubTimestamp":1790169458,"startTime":"0","endTime":"0","summary":"Maia Biotech wins Spanish, Portuguese regulatory clearance to screen patients in THIO-104 lung cancer trialMaia Biotechnology won regulatory clearance in Spain, Portugal to start screening for its Pha","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nNDL43t6JT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","BK4112","IE00B3QW5Z07.USD","IE00BN0W2T93.GBP","IE00BQXX3C00.GBP","IE00BGHQF748.EUR","LU0314104364.USD","NDAQ","LU2210150020.SGD","BK4588","IE00BN0W2W23.USD","IE00BQXX3F31.USD","IE00BQXX3D17.EUR","BK4585","MAIA","SG9999014021.USD","IE00BKPKM429.USD","IE00BN0W2V16.EUR","SG9999014013.SGD","LU2210149790.SGD","BK4139","LU2095319765.USD","SG9999014005.SGD","BCDF","SG9999014039.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669898434","title":"Maia Biotechnology Expands Pivotal Phase 3 Thio-104 Non-Small Cell Lung Cancer Trial into Spain and Portugal","url":"https://stock-news.laohu8.com/highlight/detail?id=2669898434","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669898434?lang=en_us&edition=fundamental","pubTime":"2026-09-23 21:17","pubTimestamp":1790169420,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nTUABYXMWW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MAIA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669898424","title":"Maia Biotechnology - Targets 100 Patients Dosed in Thio-104 by Year-End 2026; Interim Analysis in 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2669898424","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669898424?lang=en_us&edition=fundamental","pubTime":"2026-09-23 21:17","pubTimestamp":1790169420,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nTUABYXMWW:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MAIA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669333489","title":"MAIA Biotechnology Expands Pivotal Phase 3 THIO-104 Non-Small Cell Lung Cancer Trial into Spain and Portugal","url":"https://stock-news.laohu8.com/highlight/detail?id=2669333489","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669333489?lang=en_us&edition=fundamental","pubTime":"2026-09-23 21:17","pubTimestamp":1790169420,"startTime":"0","endTime":"0","summary":"THIO-104 advances toward key 2027 interim survival analysis CHICAGO, Sept.  23, 2026 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc. (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopha","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/23/3367552/0/en/maia-biotechnology-expands-pivotal-phase-3-thio-104-non-small-cell-lung-cancer-trial-into-spain-and-portugal.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0053666078.USD","LU0210528500.USD","BK4107","MAIA","BK4139","L","LU2487616109.SGD","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669142826","title":"Maia Biotech Says Phase 3 THIO-104 Trial in Third-Line NSCLC Enrolls 65 Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2669142826","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669142826?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:47","pubTimestamp":1790081253,"startTime":"0","endTime":"0","summary":"Maia Biotech says Phase 3 THIO-104 trial in third-line NSCLC enrolls 65 patientsMaia Biotechnology reported progress in its pivotal Phase 3 THIO-104 trial of ateganosine as third-line therapy for adva","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nNDL6XRdTd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014039.USD","SG9999014021.USD","SG9999014005.SGD","BCDF","LU2210150020.SGD","SG9999014013.SGD","IE00BN0W2T93.GBP","IE00B64PRP62.GBP","IE00BQXX3F31.USD","IE00BQXX3D17.EUR","LU2210149790.SGD","IE00BKPKM429.USD","IE00B3QW5Z07.USD","LU0314104364.USD","IE00BGHQF748.EUR","BK4112","NDAQ","IE00BQXX3C00.GBP","LU2095319765.USD","IE00BN0W2V16.EUR","BK4139","BK4588","BK4585","IE00BN0W2W23.USD","MAIA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669142844","title":"Maia Biotechnology Reports Pivotal Phase 3 Clinical Trial Progress in Advanced Non-Small Cell Lung Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2669142844","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669142844?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:47","pubTimestamp":1790081220,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nTUAC5MSVQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","MAIA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669259142","title":"MAIA Biotechnology Reports Pivotal Phase 3 Clinical Trial Progress in Advanced Non-Small Cell Lung Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2669259142","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669259142?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:47","pubTimestamp":1790081220,"startTime":"0","endTime":"0","summary":"Strong pace of patient enrollment supports continued advancement toward regulatory milestones Most recent assessment of novel telomere targeting agent sequenced with a checkpoint inhibitor showed 90.5","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/22/3366372/0/en/maia-biotechnology-reports-pivotal-phase-3-clinical-trial-progress-in-advanced-non-small-cell-lung-cancer.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4107","LU2931357623.SGD","LU0210528500.USD","LU0757428866.USD","BK4097","LU0053666078.USD","MAIA","L","IE00B19Z4B17.USD","IE00B7SZL793.SGD","LU2487616109.SGD","AEIS","LU0274383776.USD","IE0031619046.USD","BK4157","LU1815336091.USD","PRGS","BK4588","LU2089985449.USD","LU2065732104.USD","IE00B66KJ199.SGD","BK4585","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667838979","title":"Maia Biotechnology Wins $2.3 Million NIH Grant for Phase 2 NSCLC Trial Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2667838979","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667838979?lang=en_us&edition=fundamental","pubTime":"2026-09-16 20:15","pubTimestamp":1789560937,"startTime":"0","endTime":"0","summary":"Maia Biotechnology wins $2.3 million NIH grant for Phase 2 NSCLC trial expansionMaia Biotechnology secured FDA clearance for an amended IND for ateganosine, citing improved manufacturing capabilities ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nNDL3887By:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210150020.SGD","IE00BGHQF748.EUR","NDAQ","BK4139","IE00BN0W2T93.GBP","SG9999014013.SGD","BK4585","IE00BQXX3C00.GBP","IE00B3QW5Z07.USD","BK4588","IE00B64PRP62.GBP","LU0314104364.USD","MAIA","SG9999014021.USD","BK4112","IE00BQXX3F31.USD","LU2210149790.SGD","IE00BQXX3D17.EUR","IE00BKPKM429.USD","SG9999014005.SGD","LU2095319765.USD","IE00BN0W2V16.EUR","SG9999014039.USD","IE00BN0W2W23.USD","BCDF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667833983","title":"Maia Biotechnology Doses First U.S. Patient in Ongoing Phase 2 Non-Small Cell Lung Cancer Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2667833983","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667833983?lang=en_us&edition=fundamental","pubTime":"2026-09-16 20:15","pubTimestamp":1789560900,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nTUA7Q1XS6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MAIA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667498364","title":"MAIA Biotechnology Doses First U.S. Patient in Ongoing Phase 2 Non-Small Cell Lung Cancer Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2667498364","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667498364?lang=en_us&edition=fundamental","pubTime":"2026-09-16 20:15","pubTimestamp":1789560900,"startTime":"0","endTime":"0","summary":"Milestone follows FDA clearance of MAIA’s amended investigational new drug (IND) submission highlighting improved manufacturing capabilities and efficiencies U.S. expansion is funded by a $2.3 million","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/16/3363142/0/en/maia-biotechnology-doses-first-u-s-patient-in-ongoing-phase-2-non-small-cell-lung-cancer-clinical-trial.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4107","BK4588","IND","LU0210528500.USD","LU0053666078.USD","CPI","BK4139","L","BK4585","LU2487616109.SGD","ORR","MAIA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667964259","title":"Maia Biotechnology Board Member Ramiro Guerrero Boosts Stake with USD 252,284 Share Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2667964259","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667964259?lang=en_us&edition=fundamental","pubTime":"2026-09-15 20:15","pubTimestamp":1789474531,"startTime":"0","endTime":"0","summary":"Maia Biotechnology board member Ramiro Guerrero boosts stake with USD 252,284 share buyMaia Biotechnology board member Ramiro Guerrero bought 185,078 common shares in open-market trades totaling about","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nNDL1S2Q9P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","SG9999014013.SGD","SG9999014005.SGD","BCDF","IE00BQXX3C00.GBP","SG9999014039.USD","IE00BGHQF748.EUR","SG9999014021.USD","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","IE00BN0W2T93.GBP","IE00BQXX3D17.EUR","LU2095319765.USD","NDAQ","IE00BQXX3F31.USD","BK4112","LU2210150020.SGD","LU2210149790.SGD","IE00BN0W2V16.EUR","MAIA","IE00BKPKM429.USD","BK4139","BK4585","LU0314104364.USD","IE00BN0W2W23.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667642552","title":"Maia Biotechnology Announces Open Market Purchases of Company Stock by Long-Standing Board Member and CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2667642552","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667642552?lang=en_us&edition=fundamental","pubTime":"2026-09-15 20:15","pubTimestamp":1789474500,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nTUA126B7H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","MAIA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667425506","title":"Maia Biotechnology - Directors and Officers Hold 21.34% Stake as of Sept 14, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2667425506","media":"THOMSON REUTERS","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667425506?lang=en_us&edition=fundamental","pubTime":"2026-09-15 20:15","pubTimestamp":1789474500,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nTUA126B7H:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","MAIA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667642250","title":"MAIA Biotechnology Announces Open Market Purchases of Company Stock by Long-Standing Board Member and CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2667642250","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667642250?lang=en_us&edition=fundamental","pubTime":"2026-09-15 20:15","pubTimestamp":1789474500,"startTime":"0","endTime":"0","summary":"CHICAGO, Sept.  15, 2026 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc. (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company focused on developing immunotherapies fo","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/15/3362049/0/en/maia-biotechnology-announces-open-market-purchases-of-company-stock-by-long-standing-board-member-and-ceo.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2487616109.SGD","BK4107","LU0210528500.USD","BK4585","LU0053666078.USD","BK4139","MAIA","L","BK4588"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.MAIABiotech.com","stockEarnings":[{"period":"1week","weight":-0.0261},{"period":"1month","weight":-0.1642},{"period":"3month","weight":-0.1385},{"period":"6month","weight":-0.1704},{"period":"1year","weight":-0.2222},{"period":"ytd","weight":-0.268}],"compareEarnings":[{"period":"1week","weight":-0.0028},{"period":"1month","weight":0.019},{"period":"3month","weight":0.0383},{"period":"6month","weight":0.0868},{"period":"1year","weight":0.1603},{"period":"ytd","weight":0.1318}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer. The company's lead product candidate is THIO, a telomere-targeting agent that is in Phase II clinical study to evaluate its activity in patients with non-small cell lung cancer. It is also developing second generation telomere targeting agents. MAIA Biotechnology, Inc. was incorporated in 2018 and is headquartered in Chicago, Illinois.","yearOnYearQuotes":[{"month":1,"riseRate":0.75,"avgChangeRate":0.285723},{"month":2,"riseRate":0,"avgChangeRate":-0.06082},{"month":3,"riseRate":0.25,"avgChangeRate":-0.026788},{"month":4,"riseRate":0.5,"avgChangeRate":0.130553},{"month":5,"riseRate":0.75,"avgChangeRate":0.111873},{"month":6,"riseRate":0.5,"avgChangeRate":-0.089611},{"month":7,"riseRate":0.25,"avgChangeRate":-0.076547},{"month":8,"riseRate":0.2,"avgChangeRate":-0.109363},{"month":9,"riseRate":0.2,"avgChangeRate":-0.019779},{"month":10,"riseRate":0.2,"avgChangeRate":-0.041872},{"month":11,"riseRate":0.25,"avgChangeRate":-0.189158},{"month":12,"riseRate":0.5,"avgChangeRate":0.077797}],"exchange":"AMEX","name":"MAIA Biotechnology Inc.","nameEN":"MAIA Biotechnology Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"MAIA Biotechnology Inc.(MAIA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest MAIA Biotechnology Inc.(MAIA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"MAIA Biotechnology Inc.,MAIA,MAIA Biotechnology Inc.股票,MAIA Biotechnology Inc.股票老虎,MAIA Biotechnology Inc.股票老虎国际,MAIA Biotechnology Inc.行情,MAIA Biotechnology Inc.股票行情,MAIA Biotechnology Inc.股价,MAIA Biotechnology Inc.股市,MAIA Biotechnology Inc.股票价格,MAIA Biotechnology Inc.股票交易,MAIA Biotechnology Inc.股票购买,MAIA Biotechnology Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"MAIA Biotechnology Inc.(MAIA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest MAIA Biotechnology Inc.(MAIA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction